Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

RVMD FY 2017 Earnings — Revolution Medicines, Inc. Revenue & Financial Results | Market Cap Arena

RVMDRevolution Medicines, Inc.

$19B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$27M

Operating Income

-$31M

Net Income

-$31M

EPS (Diluted)

$-0.85

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$27M

Stock-Based Comp.

$141,000

Balance Sheet

Total Assets

$15M

Total Liabilities

$11M

Stockholders' Equity

$5M

Cash & Equivalents

$9M

← FY 2018 All Quarters